UNITED STATES ANTIMONY CORP SEC Filings

United States Antimony Corporation furnished a press release reporting its financial and operational results for the third quarter and nine months ended September 30, 2025.

The press release was provided as Exhibit 99.1 to this Form 8-K under Item 2.02 and is incorporated by reference. The information in Item 2.02, including Exhibit 99.1, is being furnished and is not deemed “filed” for purposes of Section 18 of the Exchange Act. The company also included customary forward‑looking statements language.

United States Antimony Corporation reported sharply higher sales and larger losses in its Q3 results. Revenue rose to $8,701,951 from $2,572,178 a year ago, driven by antimony products, while gross profit reached $2,013,442. The company posted a net loss of $4,780,700 as operating expenses jumped, including non‑cash share‑based compensation.

Year to date, revenue was $26,227,079. The balance sheet strengthened with cash and cash equivalents of $18,338,679 and held‑to‑maturity U.S. Treasury Strips at $20,157,393 amortized cost. Operating cash flow was $(6,220,686), offset by $42,415,350 provided by financing activities, including an at‑the‑market sale and a registered direct offering; warrant exercises added cash as well.

The company disclosed a five‑year IDIQ contract with the DLA Strategic Materials for antimony metal ingots, with a maximum value of $245 million through September 2030. An initial delivery order for 315,000 pounds is valued at approximately $10 million; no revenue has been recognized yet. Inventory increased to $8,413,161, PP&E to $28,121,338, and management booked a $469,822 gain on early termination of a Montana lease.

United States Antimony Corporation entered into a five-year supply agreement with a large U.S. industrial fabric manufacturer for antimony trioxide, a key ingredient in flame‑retardant materials. The agreement was executed on November 7, 2025 and reflects a multi‑year commercial commitment for product sales.

The company announced the deal via press release on November 11, 2025. The purchasing and supply agreement is filed as Exhibit 10.1, with a press release attached as Exhibit 99.1.

United States Antimony Corporation (UAMY): Patrick Dugan and the Estate of Lydia Dugan filed Amendment No. 4 to Schedule 13D, an exit filing, after selling shares and reducing their beneficial ownership below 5%.

The group reports beneficial ownership of 5,700,560 shares, representing 4.1% of the class, based on 138,878,411 shares outstanding as of October 13, 2025. Dispositions disclosed include 1,022,089 shares at $9.41 per share (transaction effected on October 28, 2025) and 1,346,278 shares at $9.29 per share (transaction effected on October 29, 2025). The filing states they ceased to be beneficial owners of more than five percent of the issuer’s securities.

United States Antimony Corporation announced the schedule for releasing its Third Quarter and Nine Months Ended September 30, 2025 financial and operating results. The company will host a conference call and webcast on November 12, 2025 at 4:15 p.m. Eastern time.

Access details are provided in a press release attached as Exhibit 99.1. The information was furnished under Item 8.01 and is not deemed filed under Section 18 of the Exchange Act.

United States Antimony Corporation filed a Form 8-K stating it issued a press release on October 30, 2025 with an operational update and a preliminary update to Fiscal 2026 revenue guidance. The press release is included as Exhibit 99.1.

The company furnished this information under Item 7.01 (Regulation FD Disclosure), which means it is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference unless specifically noted.

United States Antimony Corporation (UAMY) filed an 8‑K announcing a non‑binding, indicative proposal to acquire Larvotto Resources Limited. On October 17, 2025, USAC submitted terms offering six (6) USAC shares for every one hundred (100) Larvotto shares. The company also disclosed it has recently acquired approximately 10% of Larvotto’s ordinary shares.

The proposal is subject to negotiation and execution of a binding scheme implementation deed, Larvotto shareholder approval, regulatory approvals, and customary closing conditions. USAC furnished a related press release under Regulation FD. The disclosure outlines the proposed share‑for‑share ratio and approvals required, indicating an early, non‑binding stage in a potential combination.

United States Antimony Corporation filed a prospectus supplement for an at‑the‑market program to offer and sell up to $400,000,000 of common stock under its automatic shelf registration on Form S‑3. Sales may be made through A.G.P./Alliance Global Partners and B. Riley Securities pursuant to an amended and restated sales agreement.

Offerings will be made only by means of the prospectus supplement and the base prospectus. A legal opinion from Duane Morris LLP regarding the validity of the shares was filed as Exhibit 5.1.

United States Antimony Corporation commenced an at-the-market offering of up to $400,000,000 of common stock, to be sold from time to time through A.G.P./Alliance Global Partners and B. Riley Securities as agents or principals. Sales may be made pursuant to Rule 415(a)(4) with no minimum amount required.

The company will pay the Agents up to 3.0% of the gross sales price per share and plans to use any net proceeds to acquire antimony and other critical mineral inventory, expand leasehold positions in Alaska and Montana, pursue acquisitions, potentially increase capacity at the Madero Smelter in Mexico, and for general working capital.

As context, the last reported sale price was $16.71 per share on October 13, 2025, and shares outstanding were 138,878,411 as of that date. The filing illustrates potential dilution: at an assumed price of $16.71, pro forma as adjusted net tangible book value would be $3.24 per share, implying $13.47 per-share dilution to new investors.